RMDRESMED INC
Surgical & Medical Instruments & Apparatus
- Revenue
- $5.7B
- 9.9% YoY
- Operating margin
- 33.4%
- 1.9% YoY
- EBITDA
- $2.1B
- 11% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- -0.3×
- −$601M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear119% of net incomeCash flow under 80% of net income
- Dilutive SBCClear2% of revenueOver 10% of revenue
- Payouts exceed cash flowClear58% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear35% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $3.6B | $4.2B | $4.7B | $5.1B | $5.7B | 9.9% |
| Operating income | $1.0B | $1.1B | $1.3B | $1.7B | $1.9B | 12% |
| Net income | $779M | $898M | $1.0B | $1.4B | $1.5B | 8.7% |
| Operating cash flow | $351M | $693M | $1.4B | $1.8B | $1.8B | 3.1% |
| Capex | $135M | $120M | $99M | $90M | $156M | 74% |
| Stock-based comp | $65M | $71M | $80M | $92M | $104M | 14% |
| Buybacks | $0 | $0 | $150M | $300M | $700M | 133% |
| Dividends | $245M | $258M | $282M | $311M | $350M | 12% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $4M · 4
- Net
- −$4M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2026 | $16M | −$7M | 79 | 82 |
| FY2025 | $15M | $30M | 105 | 104 |
| FY2024 | $14M | $10M | 78 | 93 |
| FY2023 | $14M | $17M | 89 | 94 |
| FY2022 | $12M | $4M | 85 | 84 |